Dr. Barlogie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
One Gustave L. Levy Place
Box 1185
New York, NY 10029Phone+1 212-241-7873Fax+1 212-241-8608- Is this information wrong?
Education & Training
- University of Heidelberg Faculty of MedicineClass of 1965
Certifications & Licensure
- NY State Medical License 2016 - 2022
- AR State Medical License 1989 - 2022
- TX State Medical License 1976 - 2005
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma Start of enrollment: 1994 Jan 01
- UARK 2003-33, Total Therapy III Start of enrollment: 2004 Jan 01
- Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide Start of enrollment: 1998 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.Xuehan Mao, Wenqiang Yan, David Mery, Jiahui Liu, Huishou Fan, Jingyu Xu, Yan Xu, Weiwei Sui, Shuhui Deng, Dehui Zou, Chenxing Du, Shuhua Yi, Frits van Rhee, Bart Barl...> ;American Journal of Hematology. 2024 Apr 1
- Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up.Al Hadidi, S., Bailey, C., Panozzo, S., Cottler-Fox, M., Shaughnessy, J., Zhan, F., van Rhee, F., Thanendrarajan, S., Barlogie, B., Zangari, M., Ababneh, O., Schinke, ...> ;Blood Advances. 2024 Feb 13
- 2 citationsResolving the spatial architecture of myeloma and its microenvironment at the single-cell level.Lukas John, Alexandra M Poos, Alexander Brobeil, Carolina Schinke, Stefanie Huhn, Nina Prokoph, Raphael Lutz, Barbara Wagner, Maurizio Zangari, Stephan M Tirier, Jan-P...> ;Nature Communications. 2023 Aug 17
- Join now to see all
Journal Articles
- Mesenchymal Stem Cells Gene Signature in High‐Risk Myeloma Bone Marrow Linked to Suppression of Distinct IGFBP2‐Expressing Small AdipocytesBart Barlogie, Sharmilan Thanendrarajan, Carolina Schinke, British Journal of Haematology
Abstracts/Posters
- Analysis of the Sub-Clonal Structure of Smoldering Myeloma over Time Provides a New Means of Disease Monitoring and Highlights Evolutionary Trajectories Leading to Mye...Bart Barlogie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long-Term Outcome of Total Therapy Regimens: Impact of Molecular SubgroupsBart Barlogie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Role of PHF19 As a Promoter of Tumorigenicity and Therapeutic Target in Multiple MyelomaBart Barlogie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- The Mutational Landscape of Primary Plasma Cell Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Baseline and on-Treatment Bone Marrow Microenvironments Predict Myeloma Patient Outcomes and Inform Potential Intervention Strategies2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Longer Term Follow up of the  Randomized Phase III Trial SWOG S0777: Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) w...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- MCRT Webcast: Immunotherapy - St. Louis MCRT Part 1February 11th, 2022
- Minimal Residual Disease Negativity by Next-Generation Flow Cytometry Is Associated with Improved Organ Response in AL AmyloidosisFebruary 16th, 2021
- Introduction the Combination of Bortezomib, Lenalidomide, AndMay 11th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: